These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5349817)

  • 1. [Hemorrhagic complications in surgical treatment of patients with portal hypertension: their prevention and therapy].
    Patsiora MD; Eramishantsev AK
    Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):16-9. PubMed ID: 5349817
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of antifibrinolytic effects of epsilon-aminocaproic acid and enzyme inhibitors in the surgery of portal hypertension].
    Lande M; Clot-Paimboeuf C; Dentan T
    Presse Med (1893); 1971 Jan; 79(1):15-6. PubMed ID: 5539954
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrinolysis. Its resurgence during surgery of portal hypertension].
    Guilmet C; Levy E; Vergoz D
    Nouv Presse Med; 1972 Sep; 1(31):2023-4. PubMed ID: 5086764
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of epsilon-aminocaproic acid for prevention of hemorrhages as a result of surgery on patients with otosclerosis for the purpose of improving hearing].
    Gerasimenko NG; Shchurovskiĭ VV
    Zh Ushn Nos Gorl Bolezn; 1971; 31(5):101-2. PubMed ID: 5162018
    [No Abstract]   [Full Text] [Related]  

  • 5. [Various postoperative complications in portal hypertension].
    Uglov FG; Mursalova RA; Rogozov LI
    Vestn Khir Im I I Grek; 1971 Nov; 107(11):113-7. PubMed ID: 5316802
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of bleeding following enucleation of prostatic adenoma in the light of thrombelastography and treatment by means of amino caproic acid (EACA)].
    Jasiñski Z; Kups J; Gozdowski M
    Pol Przegl Chir; 1972 Oct; 44(10):Suppl:1599-602. PubMed ID: 4118674
    [No Abstract]   [Full Text] [Related]  

  • 7. Lillehei CW: Effect of epsilon aminocaproic acid upon blood loss following open-heart surgery: an analysis of 340 patients.
    Sterns LP
    Can J Surg; 1967 Jul; 10(3):304-7. PubMed ID: 6027393
    [No Abstract]   [Full Text] [Related]  

  • 8. [Post-operative hemorrhage caused by local fibrinolysis].
    Flament J
    Arch Ophtalmol Rev Gen Ophtalmol; 1969 Nov; 29(11):785-94. PubMed ID: 4243965
    [No Abstract]   [Full Text] [Related]  

  • 9. [The administration of epsilon-aminocaproic acid in surgery of the prostate].
    Szabados JC
    Ned Tijdschr Geneeskd; 1967 Apr; 111(17):816-8. PubMed ID: 6047448
    [No Abstract]   [Full Text] [Related]  

  • 10. [Apropos of the use of epsilon-aminocaproic acid in urology].
    Rouffilange F; Picard P; Radiguet de la Bastaie P
    Hemostase; 1965 Dec; 5(4):405-9. PubMed ID: 5880351
    [No Abstract]   [Full Text] [Related]  

  • 11. [Local use of epsilon-aminocaproic acid in tonsillectomy].
    Radziev MK
    Vestn Otorinolaringol; 1974; (3):92-3. PubMed ID: 4467413
    [No Abstract]   [Full Text] [Related]  

  • 12. [Risk factors and their correction during shunt operation in children with extrahepatic portal hypertension].
    Aleksandrov AE; Lekmanov AU; Leont'ev AF; Seniakovich VM
    Anesteziol Reanimatol; 1994; (3):8-10. PubMed ID: 8080137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of heparin in the postoperative period in patients with portal hypertension].
    Eramishantsev AK; Patsiora MD
    Khirurgiia (Mosk); 1969 Mar; 45(3):73-6. PubMed ID: 5375957
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of epsilon aminocaproic acid in patients operated for prostatic adenoma].
    Dibobas NM
    Urol Nefrol (Mosk); 1969; 34(2):59-61. PubMed ID: 4193655
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pre- and postoperative correction of hyposiderosis in surgical treatment of portal hypertension].
    Musalatov KhA; Gordeev PS; Mindadze NA
    Khirurgiia (Mosk); 1998; (5):18-20. PubMed ID: 9642953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of chronic pancreatitis with portal hypertension--a 19-year experience.
    Ramesh H; Jacob G; Venugopal A; Lekha V; Jacob M
    Surgery; 2008 Feb; 143(2):252-8. PubMed ID: 18242342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of fibrinogen in hemorrhagic manifestations of different origin].
    Pogosian AS; Elipian EN; Aleksandrian MA
    Zh Eksp Klin Med; 1975; 15(1):100-2. PubMed ID: 1136615
    [No Abstract]   [Full Text] [Related]  

  • 18. [A comparison of the results of different types of portal systemic shunt in treatment of portal hypertension (author's transl)].
    Bai CN
    Zhonghua Wai Ke Za Zhi; 1981 Apr; 19(4):202-5. PubMed ID: 6973450
    [No Abstract]   [Full Text] [Related]  

  • 19. [Surgery in the hemophiliac].
    Sultan Y
    Bibl Haematol; 1970; 34():182-6. PubMed ID: 5436347
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of limited site-to-side portacaval shunt in treatment of portal hypertension (author's transl)].
    Sun YQ
    Zhonghua Wai Ke Za Zhi; 1981 Apr; 19(4):195-8. PubMed ID: 7261778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.